PyInvesting

Market research

TQR.F Beijing Tong Ren Tang Chinese Medicine Company Limited

F EUR Healthcare

Latest close

0.61 —

As of 29 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
530M
P/E ratio
12.5
Analyst target
Not available
Dividend yield
59.%
Beta
0.35

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Beijing Tong Ren Tang Chinese Medicine Company Limited is currently in a long term uptrend where the price is trading 24.0% above its 200 day moving average.

From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.9.

Beijing Tong Ren Tang Chinese Medicine Company Limited's total revenue sank by 0.0% to $305M since the same quarter in the previous year.

Its net income has dropped by 0.0% to $99M since the same quarter in the previous year.

Finally, its free cash flow fell by 79.3% to $27M since the same quarter in the previous year.

Based on the above factors, Beijing Tong Ren Tang Chinese Medicine Company Limited gets an overall score of 2/5.